Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
23.84
-0.02 (-0.08%)
Jan 17, 2025, 4:00 PM EST - Market closed
Perrigo Company Revenue
Perrigo Company had revenue of $1.09B in the quarter ending September 28, 2024, a decrease of -3.23%. This brings the company's revenue in the last twelve months to $4.39B, down -5.63% year-over-year. In the year 2023, Perrigo Company had annual revenue of $4.66B with 4.58% growth.
Revenue (ttm)
$4.39B
Revenue Growth
-5.63%
P/S Ratio
0.74
Revenue / Employee
$480,525
Employees
9,140
Market Cap
3.25B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
| Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
| Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
| Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
| Dec 31, 2019 | 3.87B | -861.80M | -18.21% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Jun 27, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 400.28B |
| Johnson & Johnson | 87.70B |
| Merck & Co. | 63.17B |
| AbbVie | 55.53B |
| AstraZeneca | 51.21B |
| Novartis AG | 49.94B |
| Thermo Fisher Scientific | 42.37B |
| Abbott Laboratories | 41.22B |
PRGO News
- 14 days ago - Perrigo Expands its Scientific Office; Appoints Abbie Lennox as Executive Vice President and Chief Scientific Officer - PRNewsWire
- 2 months ago - Perrigo Company: Great Combination Of Future Growth With A Low Valuation - Seeking Alpha
- 2 months ago - Perrigo Company plc (PRGO) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Perrigo Reports Third Quarter 2024 Financial Results From Continuing Operations - PRNewsWire
- 2 months ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 3 months ago - Perrigo to Release Third Quarter 2024 Financial Results on November 6, 2024 - PRNewsWire
- 3 months ago - WNBA Star Napheesa Collier Joins Team Opill® for Candid Conversations on Women's Health - PRNewsWire
- 4 months ago - Perrigo Announces Good Start® and Dr. Browns® Brand Partnership and Launch of Infant Formula Portfolio - PRNewsWire